Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)-Reference-Cited by-同舟云学术

Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)

Published:2009-11 Issue:11 Volume:45 Page:986-990
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Locati Laura D.,Perrone Federica,Losa Marco,Mela Micol,Casieri Paola,Orsenigo Marta,Cortelazzi Barbara,Negri Tiziana,Tamborini Elena,Quattrone Pasquale,Bossi Paolo,Rinaldi Gaetana,Bergamini Cristiana,Calderone Rosa G.,Liberatoscioli Cecilia,Licitra Lisa

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference37 articles.

1. The World Health Organization’s histological classification of salivary gland tumors. A commentary on the second edition;Seifert;Cancer,1992

2. Barnes L, Eveson JW, Reichart P, et al. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005.

3. Histogenesis of salivary gland neoplasms: a postulate with prognostic implications;Batsakis;J Laryngol Otol,1989

4. A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient;Tamborini;Gastroenterology,2004

5. HER-2/neu assessment in primary chemotherapy treated breast carcinoma: no evidence of gene profile changing;Dagrada;Breast Cancer Res Treat,2003

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near-infrared photoimmunotherapy for salivary duct carcinoma;Auris Nasus Larynx;2024-04

2. Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer;International Journal of Molecular Sciences;2024-03-12

3. HER2-targeted therapies for salivary gland cancers;Oral Oncology;2024-01

4. Diagnostic reliability of c-KIT (CD117) in salivary gland tumours – A systematic review and meta-analysis;Journal of Oral and Maxillofacial Pathology;2024-01

5. ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy;Modern Pathology;2023-10